Answers are grounded in this paper and cite their sources.
Background Parkinson’s disease (PD) is clinically and biologically heterogeneous. Rapid eye movement sleep behavior disorder (RBD) is associated with a distinct and often more aggressive PD phenotype, yet minimally invasive molecular approaches to resolve RBD-related heterogeneity remain limited. Methods We performed high-resolution untargeted LC-MS/MS metabolomics on plasma-derived L1CAM-enriched extracellular vesicles (L1EVs) from 11 patients with PD without RBD (PD-noRBD), 9 patients with PD with RBD (PD-RBD), and 8 healthy controls (HC), retaining 775 QC-filtered metabolic features for downstream analysis, with 316 unique metabolites putatively annotated. Metabolomic profiles were evaluated using multivariate analysis, candidate differentially abundant metabolite screening, pathway analysis, exploratory Spearman correlation analyses with clinical variables and quantitative susceptibility mapping measures, integration with a previously generated L1EV proteomic dataset from the same cohort, and comparison with a published plasma metabolomics dataset. Results PD-noRBD showed 62 candidate differentially abundant metabolites compared with PD-RBD and 49 compared with HC, whereas only three were detected between PD-RBD and HC. Sphingolipid metabolism was a recurrent top-ranked nominal pathway-level signal in comparisons involving PD-noRBD. Selected L1EV metabolites showed nominal associations with motor severity, disease duration, constipation, type 2 diabetes mellitus, and regional brain iron deposition. Cross-omics integration supported concordance between L1EV metabolomic and metabolism-related proteomic variation. Comparison with published plasma metabolomics additionally revealed both shared lipid-related changes and differences in fold-change patterns between datasets. Conclusions Plasma L1EV metabolomics identified exploratory metabolic differences across RBD-defined PD groups, with the most prominent alterations observed in PD-noRBD. Lipid-related features, particularly those involving sphingolipid and glycerophospholipid metabolism, emerged as candidates for further investigation. These findings are hypothesis-generating and require validation in larger independent and longitudinal cohorts.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: